Key facts
- Kanza AI’s last known valuation is $65.0M (Dec 2024).
- It has raised $16.0M; the latest was Early Stage VC ($12.0M) in Dec 2024.
- Notable investors include ONCE Ventures.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Kanza AI
- ·The full record, as it builds
Funding rounds
No funding rounds for Kanza AI are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Kanza AI
Developer of an artificial health intelligence platform designed to improve quality of life through personalized, data-driven healthcare and wellness applications. The company's platform offers a curated corpus of proprietary institutional data, longitudinal health records, expert-verified knowledge spaces, and agentic AI capabilities, enabling physicians, caregivers, healthcare organizations, and individuals to deliver personalized care with trusted, clinically connected intelligence.
- Sector
- Healthcare
- HQ
- Menlo Park, CA, United States
- Founded
- 2022
- Employees
- 19
- Website
- kanza.ai/
- Ownership
- Privately Held (backing)
Kanza AI doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Kanza AI shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Kanza AI in its N-PORT filings yet. We sweep new filings monthly.